Fresh off $500M fund, Raleigh investment firm buys Durham CRO


A Raleigh-based private equity firm has added another local life sciences company to its investment portfolio.

Previous Edward Jones places first in adviser satisfaction study, neck and neck with Stifel
Next Forbes: Two Jax credit unions among Florida’s top 5